|
FDA approves Biaxin for MAC prophylaxis. Food and Drug Administration. |
1995 |
J Int Assoc Physicians AIDS Care |
pmid:11363096
|
Savarino V et al. |
Helicobacter pylori eradication and reinfection. |
1995 |
Lancet |
pmid:7783564
|
Comley JC and Sterling AM |
Effect of atovaquone and atovaquone drug combinations on prophylaxis of Pneumocystis carinii pneumonia in SCID mice. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7785975
|
Struillou L et al. |
Activities of roxithromycin against Mycobacterium avium infections in human macrophages and C57BL/6 mice. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7785988
|
Fong IW et al. |
Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group. |
1995 |
Clin Invest Med |
pmid:7788958
|
Goddard A and Logan R |
One-week low-dose triple therapy: new standards for Helicobacter pylori treatment. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:7866804
|
Weits J and Sprenger HG |
[Surgical treatment of lymphadenitis caused by non-tuberculous mycobacteria in children]. |
1995 |
Ned Tijdschr Geneeskd |
pmid:8524431
|
Nash KA and Inderlied CB |
Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8592991
|
RamÃrez Ramos A |
[Treatment of Helicobacter pylori infection: current status]. |
1995 |
Rev Gastroenterol Peru |
pmid:8520021
|
Adamek RJ et al. |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection]. |
1995 |
Dtsch. Med. Wochenschr. |
pmid:7889816
|
Midoneck SR and Etingin OR |
Clarithromycin-related toxic effects of digoxin. |
1995 |
N. Engl. J. Med. |
pmid:7477159
|
Forslund T et al. |
Disseminated cutaneous infection due to Mycobacterium chelonae in a patient with rheumatoid arthritis, amyloidosis, and renal failure. |
1995 |
Nephrol. Dial. Transplant. |
pmid:7478131
|
Cavalieri SJ et al. |
Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7492101
|
Citron DM et al. |
Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children. |
1995 |
Clin. Infect. Dis. |
pmid:7548597
|
Ishii K et al. |
A new pharmacokinetic model including in vivo dissolution and gastrointestinal transit parameters. |
1995 |
Biol. Pharm. Bull. |
pmid:7550125
|
Harris AW et al. |
Eradication of Helicobacter pylori with lansoprazole and clarithromycin. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7605863
|
Katelaris PH et al. |
A randomized prospective comparison of clarithromycin versus amoxycillin in combination with omeprazole for eradication of Helicobacter pylori. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7605864
|
Yousfi MM et al. |
Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7605865
|
Chevalley GF et al. |
[Uveitis associated with rifabutin treatment. Apropos of 3 patients]. |
1995 |
Klin Monbl Augenheilkd |
pmid:7609395
|
Blum AL et al. |
[Functional dyspepsia: approaches to Helicobacter pylori eradication therapy]. |
1995 |
Leber Magen Darm |
pmid:7609589
|
Labenz J et al. |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori]. |
1995 |
Leber Magen Darm |
pmid:7609590
|
Reppun JI |
From prontolyn to biaxin: the half-century of antibiotics. |
1995 |
Hawaii Med J |
pmid:7628918
|
Chin DP and Hopewell PC |
How to treat bacteraemic Mycobacterium avium complex disease. |
1995 |
Lancet |
pmid:7564723
|
Kuhn SM et al. |
Treatment of Mycobacterium marinum facial abscess using clarithromycin. |
1995 |
Pediatr. Infect. Dis. J. |
pmid:7567299
|
Lacassin F et al. |
Clarithromycin-minocycline combination as salvage therapy for toxoplasmosis in patients infected with human immunodeficiency virus. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7695324
|
Tseng AL and Walmsley SL |
Rifabutin-associated uveitis. |
1995 |
Ann Pharmacother |
pmid:8573961
|
Moayyedi P et al. |
Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574714
|
Fujioka T et al. |
Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574733
|
Deltenre M et al. |
Omeprazole-based antimicrobial therapies: results in 198 Helicobacter pylori-positive patients. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574734
|
Fukuda Y et al. |
Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574735
|
Graham DY |
Clarithromycin for treatment of Helicobacter pylori infections. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574737
|
Takimoto T et al. |
Dual therapy with lansoprazole and clarithromycin for eradication of Helicobacter pylori. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574739
|
Uemura N et al. |
Effect of Helicobacter pylori eradication on the healing and recurrence of peptic ulcer: combination therapy with low-dose omeprazole and clarithromycin. |
1995 |
Eur J Gastroenterol Hepatol |
pmid:8574740
|
Ishii K et al. |
In vitro dissolution tests corresponding to the in vivo dissolution of clarithromycin tablets in the stomach and intestine. |
1995 |
Chem. Pharm. Bull. |
pmid:8575034
|
Diehl HG |
[One week triple therapy for eradication of Helicobacter pylori infection: simple and effective]. |
1995 |
Leber Magen Darm |
pmid:8577220
|
Götz JM et al. |
Triple therapy with ranitidine, clarithromycin, and metronidazole in the treatment of Helicobacter pylori. |
1995 |
Scand. J. Gastroenterol. Suppl. |
pmid:8578230
|
Pavlopoulou J et al. |
Randomized controlled study of clarithromycin versus cefaclor suspensions in the treatment of acute otitis media in children. |
1995 |
J Chemother |
pmid:8904139
|
Nishi K et al. |
[Effect of clarithromycin on symptoms and mucociliary transport in patients with sino-bronchial syndrome]. |
1995 |
Nihon Kyobu Shikkan Gakkai Zasshi |
pmid:8821993
|
Parasakthi N and Goh KL |
Primary and acquired resistance to clarithromycin among Helicobacter pylori strains in Malaysia. |
1995 |
Am. J. Gastroenterol. |
pmid:7872306
|
Kadayifçi A et al. |
Low dose clarithromycin plus omeprazole eradicates Helicobacter pylori in duodenal ulcer disease. |
1995 |
Am. J. Gastroenterol. |
pmid:7872307
|
Wallace RJ et al. |
Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection. |
1995 |
J. Infect. Dis. |
pmid:7876634
|
Moorthy RS and Rao NA |
Atypical mycobacterial wound infection after blepharoplasty. |
1995 |
Br J Ophthalmol |
pmid:7880802
|
Yoshizawa A et al. |
[Legionella pneumonia diagnosed by urinary antigen detection]. |
1995 |
Nihon Kyobu Shikkan Gakkai Zasshi |
pmid:7791279
|
Lounis N et al. |
Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793860
|
Fattorini L et al. |
In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793873
|
|
New drug applications sought. |
1995 |
AIDS Alert |
pmid:11362777
|
Smart T |
Cryptosporidiosis at ICAAC. |
1995 |
GMHC Treat Issues |
pmid:11362913
|
|
Researchers find new drugs to fight MAC. |
1995 |
AIDS Alert |
pmid:11362925
|
Claussen DW |
The most commonly prescribed medications in the United States: Part 3. |
1995 Jul-Aug |
Gastroenterol Nurs |
pmid:7654815
|
Kees F et al. |
Serum and cellular pharmacokinetics of clarithromycin 500 mg q.d. and 250 mg b.i.d. in volunteers. |
1995 May-Jun |
Infection |
pmid:7499006
|